The beneficial effects of Tregs on viral myocarditis make them potential therapeutic targets, and factors that stimulate Tregs such as IL-37 and thrombospondin-2 have been shown to ameliorate myocarditis in animal models [135,140]. Here, IL37 is linked to viral myocarditis.